Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
40
SKHCF Quote, Financials, Valuation and Earnings
Last price:
$16.00
Seasonality move
:
1.13%
Day range:
$16.00 - $16.00
52-week range:
$12.70 - $19.34
Dividend yield:
0%
P/E ratio:
23.19x
P/S ratio:
1.26x
P/B ratio:
1.61x
Volume:
30
Avg. volume:
5.7K
1-year change:
-9.28%
Market cap:
$7.9B
Revenue:
$6.1B
EPS (TTM):
$0.69
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SKHCF
Sonic Healthcare Ltd.
|
-- | -- | -- | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | $12.00 |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | $9.50 |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -- | -- | $16.49 |
|
MESO
Mesoblast Ltd.
|
$20.3M | -- | -100% | -- | $35.00 |
|
PPCB
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SKHCF
Sonic Healthcare Ltd.
|
$16.00 | -- | $7.9B | 23.19x | $0.28 | 0% | 1.26x |
|
ATHE
Alterity Therapeutics Ltd.
|
$3.42 | $12.00 | $62M | -- | $0.00 | 0% | 3.58x |
|
IMMP
Immutep Ltd.
|
$1.80 | $9.50 | $262M | -- | $0.00 | 0% | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
$15.05 | $16.49 | $25.1M | -- | $0.00 | 0% | 680.02x |
|
MESO
Mesoblast Ltd.
|
$17.87 | $35.00 | $2.3B | -- | $0.00 | 0% | 125.41x |
|
PPCB
|
$11.98 | -- | $158.1K | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SKHCF
Sonic Healthcare Ltd.
|
36.93% | 0.454 | -- | 0.84x |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -1.575 | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | 0.640 | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-6.76% | 5.445 | 5.57% | 0.07x |
|
MESO
Mesoblast Ltd.
|
-- | 0.345 | -- | -- |
|
PPCB
|
-- | 4.794 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SKHCF
Sonic Healthcare Ltd.
|
-- | -- | 4.54% | 6.72% | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -784.09% | -1083.16% | -- | -- |
|
MESO
Mesoblast Ltd.
|
-- | -- | -- | -- | -- | -- |
|
PPCB
|
-- | -$290.8K | -- | -- | -- | -$235.5K |
Sonic Healthcare Ltd. vs. Competitors
-
Which has Higher Returns SKHCF or ATHE?
Alterity Therapeutics Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Alterity Therapeutics Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B ATHEAlterity Therapeutics Ltd.-- -- -- -
What do Analysts Say About SKHCF or ATHE?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Alterity Therapeutics Ltd. has an analysts' consensus of $12.00 which suggests that it could grow by 250.88%. Given that Alterity Therapeutics Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Alterity Therapeutics Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 ATHEAlterity Therapeutics Ltd.0 0 0 -
Is SKHCF or ATHE More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison Alterity Therapeutics Ltd. has a beta of 0.023, suggesting its less volatile than the S&P 500 by 97.656%.
-
Which is a Better Dividend Stock SKHCF or ATHE?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. Alterity Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. Alterity Therapeutics Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or ATHE?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Alterity Therapeutics Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Alterity Therapeutics Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.19x while Alterity Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.26x versus 3.58x for Alterity Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.26x 23.19x -- -- ATHEAlterity Therapeutics Ltd.3.58x -- -- --
-
Which has Higher Returns SKHCF or IMMP?
Immutep Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Immutep Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B IMMPImmutep Ltd.-- -- -- -
What do Analysts Say About SKHCF or IMMP?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Immutep Ltd. has an analysts' consensus of $9.50 which suggests that it could grow by 427.78%. Given that Immutep Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Immutep Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 IMMPImmutep Ltd.1 0 0 -
Is SKHCF or IMMP More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison Immutep Ltd. has a beta of 1.925, suggesting its more volatile than the S&P 500 by 92.469%.
-
Which is a Better Dividend Stock SKHCF or IMMP?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. Immutep Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. Immutep Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or IMMP?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Immutep Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Immutep Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.19x while Immutep Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.26x versus -- for Immutep Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.26x 23.19x -- -- IMMPImmutep Ltd.-- -- -- --
-
Which has Higher Returns SKHCF or KZIA?
Kazia Therapeutics Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Kazia Therapeutics Ltd.'s return on equity of -1083.16%.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B KZIAKazia Therapeutics Ltd.-- -- -$6.3M -
What do Analysts Say About SKHCF or KZIA?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Kazia Therapeutics Ltd. has an analysts' consensus of $16.49 which suggests that it could grow by 9.6%. Given that Kazia Therapeutics Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Kazia Therapeutics Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 KZIAKazia Therapeutics Ltd.0 0 0 -
Is SKHCF or KZIA More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison Kazia Therapeutics Ltd. has a beta of 1.672, suggesting its more volatile than the S&P 500 by 67.185%.
-
Which is a Better Dividend Stock SKHCF or KZIA?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. Kazia Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. Kazia Therapeutics Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or KZIA?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Kazia Therapeutics Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Kazia Therapeutics Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.19x while Kazia Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.26x versus 680.02x for Kazia Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.26x 23.19x -- -- KZIAKazia Therapeutics Ltd.680.02x -- -- --
-
Which has Higher Returns SKHCF or MESO?
Mesoblast Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Mesoblast Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B MESOMesoblast Ltd.-- -- -- -
What do Analysts Say About SKHCF or MESO?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Mesoblast Ltd. has an analysts' consensus of $35.00 which suggests that it could grow by 95.86%. Given that Mesoblast Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Mesoblast Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 MESOMesoblast Ltd.1 0 0 -
Is SKHCF or MESO More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison Mesoblast Ltd. has a beta of 2.025, suggesting its more volatile than the S&P 500 by 102.508%.
-
Which is a Better Dividend Stock SKHCF or MESO?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. Mesoblast Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. Mesoblast Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or MESO?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Mesoblast Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Mesoblast Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.19x while Mesoblast Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.26x versus 125.41x for Mesoblast Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.26x 23.19x -- -- MESOMesoblast Ltd.125.41x -- -- --
-
Which has Higher Returns SKHCF or PPCB?
has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHCFSonic Healthcare Ltd.-- -- $8.2B PPCB-- -$0.00 -- -
What do Analysts Say About SKHCF or PPCB?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that Sonic Healthcare Ltd. has higher upside potential than , analysts believe Sonic Healthcare Ltd. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings SKHCFSonic Healthcare Ltd.0 0 0 PPCB0 0 0 -
Is SKHCF or PPCB More Risky?
Sonic Healthcare Ltd. has a beta of 0.978, which suggesting that the stock is 2.167% less volatile than S&P 500. In comparison has a beta of 1.881, suggesting its more volatile than the S&P 500 by 88.104%.
-
Which is a Better Dividend Stock SKHCF or PPCB?
Sonic Healthcare Ltd. has a quarterly dividend of $0.28 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 100.05% of its earnings as a dividend. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKHCF or PPCB?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than 's net income of -$354.3K. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.19x while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.26x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHCFSonic Healthcare Ltd.1.26x 23.19x -- -- PPCB-- -- -- -$354.3K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 48.08% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 6.66% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 6.48% over the past day.
